Ginkgo Bioworks Holdings, Inc. (DNA) is listed on NYSE in the Healthcare sector Β· Biotechnology industry. The current price is 6.80, down -3.27% from the previous close. Market cap is approximately $457.9M.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
ROE of -59.94% is below average. Distinguish between structural reasons (capital-intensive industry) and cyclical earnings weakness.
D/E of 96.15 indicates high leverage. Watch interest coverage and free cash flow closely, especially across rate cycles.
Revenue is contracting at -48.50% year-over-year. Distinguishing cyclical weakness from structural market decline is the central question.
Demographic-driven structural demand growth is a long-running tailwind for healthcare.
Ginkgo Bioworks Holdings, Inc. currently trades in the bottom 12% of its 52-week range (5.37β17.58). Prices near the 52-week low can mean the market has already priced in bad news, or that a downtrend is still underway β the earnings trend is what separates the two.
The day's high-to-low spread reached 6.80%, with a -3.27% move. Wide sessions frequently follow earnings, filings, or sector news, so identifying the catalyst matters.
Ginkgo Bioworks Holdings, Inc. (DNA) is listed on NYSE, with recent volume of 376,136 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app